Skip to main content
George Yendewa, MD, Infectious Disease, Cleveland, OH, University Hospitals Cleveland Medical Center

GeorgeYendewaMDMPH&TM FACP FIDSA

Infectious Disease • Cleveland, OH

HIV/AIDS Medicine, International Health, Travel & Tropical, Microbiology, STD Medicine

Assistant Professor of Medicine

Join to view full profile

Dr. Yendewa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yendewa's full profile

Already have an account?

  • Office

    UH Cleveland Medical Center
    11100 Euclid Ave Department of Medicine-Infectious Diseases & HIV Medicine
    Cleveland, OH 44106
    Phone+1 216-844-8500
    Fax+1 216-844-1632
  • Is this information wrong?

Education & Training

  • University Hospitals Cleveland Medical Center
    University Hospitals Cleveland Medical CenterPost-Doctoral Fellowship, Molecular Virology, Pathology, and Global Health, 2017 - 2018
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 2015 - 2017
  • One Brooklyn Health System/Brookdale University Hospital and Medical Center
    One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2012 - 2015
  • Tulane University
    Tulane UniversityMPH&TM, Tropical Medicine, 2010 - 2014
  • Charles University in Prague Faculty of Medicine
    Charles University in Prague Faculty of MedicineClass of 2008, MD

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2017 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition  
    Haslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, Altman MC, Krammer F, van Bakel H; IMPACC Network;..., Nature Communications, 1/9/2024
  • Ophthalmic Manifestations among HIV Patients at the Main Tertiary Hospital in Freetown, Sierra Leone: A Cross-Sectional Study  
    Mustapha J, Namanga ES, Idriss B, Sesay D, Jiba DF, Russell JBW, Vandy MJ, Deen GF, Yendewa GA, Lakoh S, Venereology, 7/4/2022

Abstracts/Posters

  • Characterizing COVID-19 presentation and clinical outcomes in HIV patients in the US.
    Yendewa GA, Perez JA, Schlick K, Tribout H, McComsey GA, Conference on Retroviruses and Opportunistic Infections (2021) [CROI Abstract 548]., 3/6/2021
  • Characterizing first viral failures among antiretroviral therapy initiators in the US
    Davy-Mendez T, Napravnik S, Wohl DA, Eaton EF, Moore R, Cachay ER, Christopoulos K, Yendewa GA, Mayer KH, Kitahata MM, Eron JJ, for the Centers for AIDS Research Netw..., Conference on Retroviruses and Opportunistic Infections (2021) [CROI Abstract 410]., 3/6/2021
  • Second antiretroviral therapy regimen in viremic people with HIV in the US, 2008-2018
    Davy-Mendez T, Napravnik S, Wohl DA, Eaton EF, Moore R, Cachay ER, Christopoulos K, Yendewa GA, Mayer KH, Kitahata MM, Eron JJ, for the Centers for AIDS Research Netw..., Conference on Retroviruses and Opportunistic Infections (2021) {CROI Abstract 411], 3/6/2021
  • Join now to see all

Press Mentions

  • IDSA Honors 175 Distinguished Physicians, Scientists with FIDSA Designation
    IDSA Honors 175 Distinguished Physicians, Scientists with FIDSA DesignationAugust 17th, 2022
  • University Hospitals Trial Investigating New Drug That Could Help Patients Recover Faster from Mild Cases of COVID-19
    University Hospitals Trial Investigating New Drug That Could Help Patients Recover Faster from Mild Cases of COVID-19March 10th, 2021
  • University Hospitals Ready Initiation of BNT162b2 Phase 2/3 COVID-19 Vaccine Trial Next Week: Seeking Minority Participation
    University Hospitals Ready Initiation of BNT162b2 Phase 2/3 COVID-19 Vaccine Trial Next Week: Seeking Minority ParticipationSeptember 11th, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • Czech

Hospital Affiliations

Dr. George Yendewa, Dr. George Yendewa, MD, Dr. G Yendewa